S & P / ASX200 Drops As Successful Listed Hotel Reservations Provider
SiteMinder achieved total annual revenue of AU $ 101.0 million in fiscal 2021 and total recurring annual revenue of AU $ 104.9 million in June 2021. Navigate the pandemic .
All of that enthusiastic talk about the ASX continuing its momentum through morning trading has fizzled out as the market is down today.
The S & P / ASX200 lost 11.80 points or 0.16% to 7,445.10 after hitting a new 20-day high.
Over the past five days, the index has gained 1.01% and is currently at 2.46% of its 52 week high.
The worst performing stocks at the time of writing were Polynovo Limited down 7.69% and Clinuvel Pharmaceuticals (ASX: CUV) Ltd down 7.15%.
The company to watch this morning was Siteminder, which debuted on the ASX, up 36%.
The hotel reservations provider is capped at $ 1.4 billion, following its oversubscribed $ 627 million IPO, which saw the issuance of 123 million shares at $ 5.06.
“Today again reminds us that the innovators and market leaders of the world can emerge from Australia,” said General Manager and CEO of SiteMinder, Sankar Narayan.
“We are grateful to our employees, customers, partners and investors for supporting us throughout our 15 year journey to date.
“In particular, I am delighted with the extremely high quality of the shareholders who have joined us on our upcoming trip.”
SiteMinder achieved total annual revenue of AU $ 101.0 million in fiscal year 2021 and total recurring annual revenue of AU $ 104.9 million in June 2021. Revenue from the company have remained resilient during the height of COVID-19, even as SiteMinder has helped its tens of thousands of hotel customers navigate the pandemic.
“In many ways, we are just getting started. We are very happy to have taken this step, which represents the next step in the SiteMinder business and our ongoing evolution, ”said Narayan.
“The global hospitality industry has evolved like never before in recent times. The need for technologies like SiteMinder’s hotel commerce platform is of paramount importance as hotels have had to rapidly transform digitally, while adapting to the changing needs and behaviors of their guests.
Speaking of being on the boards …
Invigor Group (ASX: IVO) has received pledges to raise $ 8.6 million, priced at $ 0.10 per share, for the issuance of 86 million additional shares ahead of its request to resume trading, for which ASX has communicated its approval, subject to the planned restructuring.
Read: Invigor Group Seeks To Revive Trading As Data Analytics Industry Grows Rapidly
Invigor is a B2B data intelligence and solutions company that turns data analytics into dollars for the retail and service industries.
We hope to see him on stage again in the coming weeks.
On the front of the small cap
Golden Rim Resources Ltd (ASX: GMR) is up 16.67%, launching its second round of resource definition drilling on the Kada gold project in Guinea ahead of a first resource estimate.
Creso Pharma Ltd (ASX: CPH, OTCQB: COPHF) is up 12.59% after wholly owned Canada-based psychedelics company Halucenex Life Sciences Inc. receives results described as “exceptional” from initiatives of laboratory tests, highlighting the quality of Psilocybin from Halucenex API.
OzAurum Resources Ltd (ASX: OZM) is up 9.38%. OZM has encountered extensive gold impacts during reverse circulation (RC) drilling at the Mulgabbie North project, northeast of Kalgoorlie in Western Australia.
Elementos Ltd (ASX: ELT, OTC: ELTLF) is up 8%. ELT exceeded initial expectations with a 50% increase in the total mineral resource estimate (MRE) of its 100% owned Oropesa Tin project in Spain to 18.86 million tonnes at 0.40% of tin with a cutoff of 0.15% tin.
Red 5 Ltd (ASX: RED) is up 2.86% as it gets closer to gold production.
Volt Resources Ltd (ASX: VRC) Up 3.57%, Establishing Proof of Concept for Use of Bunyu Project Flake Graphite in Battery Anodes, Confirming Successful Battery Cell Cycle Test Results lithium-ion using coated purified spheronized graphite (CSPG).